MARKET RADAR
SENSEX     NIFTY      
Elder Pharmaceuticals Homepage >> Stock Price >> Elder Pharma >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages

Elder Pharmaceuticals

  BSE: 532322  |  NSE: ELDERPHARM  |  ISIN: INE975A01015
    
Add to Portfolio : Buy Date Qty Price |
346.10 -1.40 (-0.40%)
BSE : Feb 10, 17:00
Open 348.10 Vol 35,400
High 352.35 52 Wk 435.00
Low 346.05 52 Wk 328.00
Prev. Close 347.50    
345.85 -1.90 (-0.55%)
NSE : Feb 10, 17:00
Open 350.95 Vol 27,963
High 352.90 52 Wk 419.70
Low 344.05 52 Wk 329.00
Prev. Close 347.75    
- Related links
Track Elder Pharmaceuticals 24x7
Get price sensitive and timely news updates on your mobile for just Re 1 a day
Activate Now
  Bid Offer
Price 0.00 0.00
Quantity 0.00 0.00
  Bid Offer
Price 346.10 347.75
Quantity 18.00 26.00
Market Cap 710.78 | * EPS (TTM) 38.88 | * P/E 8.90 | * P/C 6.66
* Book Value 297.56 | * Price/Book 1.16 | Div(%) 30.00 | Div Yield(%) 0.87
Market Lot 1.00 | Face Value 10.00 | Industry P/E 11.00
* As per latest stand alone adjusted profit after extra-ordinary items.

Historic Prices of Elder Pharma

on 1 week 1 month 3 month 1 year 2 year 3 year
1 YearCurrent% Gain/Loss
Open Price 369.00348.10
High Price 369.00352.35
Low Price 355.00346.05
Last Price 360.10346.10-3.89
Volume4273835400-17.17

Financials of Elder Pharma

Income Statement (Sep '11) (Mar '11)
  Quarterly Annual
Net Sales 253.09 827.16
Other Income 1.87 5.86
PBDIT 56.31 182.03
Net Profit 22.39 71.29
Profit & Loss | Half Yearly Results | Quarterly Results
Balance Sheet
Total Share Capital 20.57
Net Worth 611.12
Total Debt 735.35
Net Block 475.77
Investments 10.87
Net Current Assets 766.79
Total Assets 1346.46
Balance Sheet | Finished Goods | Raw Materials

Mutual Funds Holding - Elder Pharma

Scheme No. of Shares
This stock is not held by any Mutual Fund over the last 6 months.

Compare with Peers

What's your call on Elder Pharma

Experience the thrills of
investing with no risk

Community on Elder Pharma

News Events - Elder Pharma

BSE / NSE Notices - Elder Pharma

Expert Advice - Elder Pharma

No Expert Advice in the last 7 days

Queries on Elder Pharma

No Queries in the last 7 days

Groups: Pharmaceuticals

Company Last Price Market Cap
Sun Pharma 541.30 56,056.05
Cipla 349.00 28,021.96
Dr Reddys Labs 1,619.85 27,452.54
Lupin 458.80 20,487.26
Ranbaxy Labs 443.30 18,679.03
more...

Compare with peers

Simple Moving Averages - Elder Pharma

Days BSE NSE
30 347.11 347.05
50 350.20 350.22
150 372.99 372.95
200 371.05 371.02

Company Facts - Elder Pharma

Registered Address

Elder House,
Plot No. C-9, Dalia Industrial Estate,,Off Veera Desai Road,
Mumbai
Maharashtra
400053

Tel: 022-26730058
Fax: 022-26730051
Email: corporate@elderindia.com
Website: http://www.elderindia.com

Registrars

Link Intime India Pvt. Ltd. C-13, Pannalal Silk Mill Compound,
LBS Marg,
Bhandup (West)

Mumbai - 400078
Maharashtra

Tel: 022-25960320
Fax: 022-25960329
Email: rnt.helpdesk@linkintime.co.in
Website: http://www.linkintime.co.in

Management - Elder Pharma

Name Designation
Jagdish Saxena Chairman and Managing director
Yusuf Karim Khan Executive Director
Joginder Singh Juneja Director
Michael Bastian Director
S Jayaram Director
Urvashi Saxena Director
Name Designation
Alok Saxena Joint Managing Director
R Srinivasan Director
Sailendra Narain Director
Saleem Shervani Director
Edoardo Carlo Richter Director
Type
S Elder Pharma
SMS to 51818 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Block Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
India gold demand returns as prices ease. Will gold prices correct further?
Yes
No
 

Follow moneycontrol.com